Skip to main content
Log in

Designing micro- and nano-particles for treating rheumatoid arthritis

  • Review
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic, destructive autoimmune disease that can cause disability and have a negative socioeconomic impact. Despite significant advances in therapeutic options, limitations on the routes of administration and the requirement for frequent and long-term dosing often lead to systemic adverse effects and patient non-compliance. Micro and nanoparticle systems that selectively deliver drugs to inflamed synovium have the potential to improve drug efficacy while leaving extrasynovial tissues unaffected. This review summarizes key design parameters of RA-targeted drug carriers and discusses design considerations for improving RA therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Avnir, Y., Ulmansky, R., Wasserman, V., Even Chen, S., Broyer, M., Barenholz, Y., and Naparstek, Y., Amphipathic weak acid glucocorticoid prodrugs remote loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: A novel approach to treating autoimmune arthritis. Arthritis Rheum., 58, 119–129 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Butoescu, N., Seemayer, C. A., Foti, M., Jordan, O., and Doelker, E., Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials, 30, 1772–1780 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Champion, J. A. and Mitragotri, S., Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. U. S. A., 103, 4930–4934 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Champion, J. A., Katare, Y. K., and Mitragotri, S., Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Release, 121, 3–9 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Chandrasekar, D., Sistla, R., Ahmad, F. J., Khar, R. K., and Diwan, P. V., Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. J. Biomed. Mater. Res. A, 82, 92–103 (2007).

    PubMed  Google Scholar 

  • Chithrani, B. D., Ghazani, A. A., and Chan, W. C. W., Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano lett., 6, 662–668 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Council, E. R., Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Ann. Rheum. Dis., 16, 277–289 (1957).

    Article  Google Scholar 

  • Decuzzi, P., Pasqualini, R., Arap, W., and Ferrari, M., Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res., 26, 235–243 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Doshi, N., Prabhakarpandian, B., Rea-Ramsey, A., Pant, K., Sundaram, S., and Mitragotri, S., Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. J. Control. Release, 146, 196–200 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Emery, P., Breedveld, F. C., Hall, S., Durez, P., Chang, D. J., Robertson, D., Singh, A., Pedersen, R. D., Koenig, A. S., and Freundlich, B., Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet, 372, 375–382 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Everts, M., Koning, G. A., Kok, R. J., Asgeirsdottir, S. A., Vestweber, D., Meijer, D. K., Storm, G., and Molema, G., In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium. Pharm. Res., 20, 64–72 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Fang, C., Shi, B., Pei, Y. Y., Hong, M. H., Wu, J., and Chen, H. Z., In vivo tumor targeting of tumor necrosis factoralpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur. J. Pharm. Sci., 27, 27–36 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Feldmann, M. and Maini, S. R. N., Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev., 223, 7–19 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Firestein, G. S., Evolving concepts of rheumatoid arthritis. Nature, 423, 356–361 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Furst, D. E., The risk of infections with biologic therapies for rheumatoid arthritis. Semin. Arthritis Rheum., 39, 327–346 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Garrood, T. and Pitzalis, C., Targeting the inflamed synovium: the quest for specificity. Arthritis Rheum., 54, 1055–1060 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Gerlag, D. M., Borges, E., Tak, P. P., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., Ruoslahti, E., and Firestein, G. S., Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res., 3, 357–361 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., and Langer, R., Biodegradable long-circulating polymeric nanospheres. Science, 263, 1600–1603 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Gregoriadis, G., Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol., 13, 527–537 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Hafstrom, I., Albertsson, K., Boonen, A., Van Der Heijde, D., Landewe, R., and Svensson, B., Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann. Rheum. Dis., 68, 508–513 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Hattori, Y., Sakaguchi, M., and Maitani, Y., Folate-linked lipid-based nanoparticles deliver a NFkappaB decoy into activated murine macrophage-like RAW264.7 cells. Biol. Pharm. Bull., 29, 1516–1520 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Hollander, J., Brown, E., Jessar, R., and Brown, C., Comparative effects of use of hydrocortisone as a local antiarthritic agent. JAMA, 147, 1629–1635 (1951).

    Article  CAS  Google Scholar 

  • Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., and Cheresh, D. A., Tumor regression by targeted gene delivery to the neovasculature. Science, 296, 2404–2407 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Horisawa, E., Hirota, T., Kawazoe, S., Yamada, J., Yamamoto, H., Takeuchi, H., and Kawashima, Y., Prolonged antiinflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm. Res., 19, 403–410 (2002a).

    Article  PubMed  CAS  Google Scholar 

  • Horisawa, E., Kubota, K., Tuboi, I., Sato, K., Yamamoto, H., Takeuchi, H., and Kawashima, Y., Size-dependency of DLlactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm. Res., 19, 132–139 (2002b).

    Article  PubMed  CAS  Google Scholar 

  • Ishihara, T., Kubota, T., Choi, T., and Higaki, M., Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate. J. Pharmacol. Exp. Ther., 329, 412–417 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Jamar, F., Chapman, P., Manicourt, D., Glass, D., Haskard, D., and Peters, A., A comparison between 111In-anti-Eselectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Br. J. Radiol., 70, 473 (1997).

    PubMed  CAS  Google Scholar 

  • Khoury, M., Louis-Plence, P., Escriou, V., Noel, D., Largeau, C., Cantos, C., Scherman, D., Jorgensen, C., and Apparailly, F., Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum., 54, 1867–1877 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Koch, A., Angiogenesis as a target in rheumatoid arthritis. Ann. Rheum. Dis., 62, ii60-ii67 (2003).

    Google Scholar 

  • Koning, G. A., Schiffelers, R. M., Wauben, M. H., Kok, R. J., Mastrobattista, E., Molema, G., Ten Hagen, T. L., and Storm, G., Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum., 54, 1198–1208 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Lawrence, R. C., Helmick, C. G., Arnett, F. C., Deyo, R. A., Felson, D. T., Giannini, E. H., Heyse, S. P., Hirsch, R., Hochberg, M. C., Hunder, G. G., Liang, M. H., Pillemer, S. R., Steen, V. D., and Wolfe, F., Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum., 41, 778–799 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Levick, J. R., Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J. Rheumatol., 17, 579–582 (1990).

    PubMed  CAS  Google Scholar 

  • Liang, L. S., Jackson, J., Min, W., Risovic, V., Wasan, K. M., and Burt, H. M., Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. J. Pharm. Sci., 93, 943–956 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Liang, L. S., Wong, W., and Burt, H. M., Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits. J. Pharm. Sci., 94, 1204–1215 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Liggins, R. T., Cruz, T., Min, W., Liang, L., Hunter, W. L., and Burt, H. M., Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits. Inflamm. Res., 53, 363–372 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Listing, J., Strangfeld, A., Kary, S., Rau, R., Von Hinueber, U., Stoyanova-Scholz, M., Gromnica-Ihle, E., Antoni, C., Herzer, P., Kekow, J., Schneider, M., and Zink, A., Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum., 52, 3403–3412 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Mansouri, S., Cuie, Y., Winnik, F., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, E., and Fernandes, J. C., Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27, 2060–2065 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Mcneil, J. and Binette, J., Prevalence of disabilities and associated health conditions among adults—United States, 1999. MMWR Morb. Mortal. Wkly. Rep., 50, 120–125 (2001).

    Google Scholar 

  • Metselaar, J. M., Wauben, M. H., Wagenaar-Hilbers, J. P., Boerman, O. C., and Storm, G., Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum., 48, 2059–2066 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Metselaar, J. M., Van Den Berg, W. B., Holthuysen, A. E., Wauben, M. H., Storm, G., and Van Lent, P. L., Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheum. Dis., 63, 348–353 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Montesinos, M. C., Takedachi, M., Thompson, L. F., Wilder, T. F., Fernandez, P., and Cronstein, B. N., The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5’-nucleotidase: findings in a study of ecto-5’-nucleotidase gene-deficient mice. Arthritis Rheum., 56, 1440–1445 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Muller, R. H., Mader, K., and Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery — a review of the state of the art. Eur. J. Pharm. Biopharm., 50, 161–177 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Naor, D. and Nedvetzki, S., CD44 in rheumatoid arthritis. Arthritis Res. Ther., 5, 105–115 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Natarajan, V., Krithica, N., Madhan, B., and Sehgal, P. K., Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. J. Pharm. Sci., 100, 195–205 (2011).

    Article  PubMed  CAS  Google Scholar 

  • O’dell, J. R., Haire, C. E., Erikson, N., Drymalski, W., Palmer, W., Eckhoff, P. J., Garwood, V., Maloley, P., Klassen, L. W., Wees, S., Klein, H., and Moore, G. F., Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N. Engl. J. Med., 334, 1287–1291 (1996).

    Article  PubMed  Google Scholar 

  • Owens, D. E. 3rd and Peppas, N. A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm., 307, 93–102 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Paulos, C. M., Turk, M. J., Breur, G. J., and Low, P. S., Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv. Drug Deliv. Rev., 56, 1205–1217 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Paulos, C. M., Varghese, B., Widmer, W. R., Breur, G. J., Vlashi, E., and Low, P. S., Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res. Ther., 8, R77 (2006).

    Article  PubMed  Google Scholar 

  • Pincus, T., Marcum, S. B., and Callahan, L. F., Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J. Rheumatol., 19, 1885–1894 (1992).

    PubMed  CAS  Google Scholar 

  • Piscaer, T. M., Müller, C., Mindt, T. L., Lubberts, E., Verhaar, J. A., Krenning, E. P., Schibli, R., De Jong, M., and Weinans, H., Imaging of activated macrophages in experimental osteoarthritis using folate targeted animal singlephoton-emission computed tomography/computed tomography. Arthritis Rheum., 63, 1898–1907 (2011).

    Article  PubMed  Google Scholar 

  • Ratcliffe, J. H., Hunneyball, I. M., Wilson, C. G., Smith, A., and Davis, S. S., Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits. J. Pharm. Pharmacol., 39, 290–295 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Roh, K. H., Martin, D. C., and Lahann, J., Biphasic Janus particles with nanoscale anisotropy. Nat. Mater., 4, 759–763 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Romberg, B., Hennink, W. E., and Storm, G., Sheddable coatings for long-circulating nanoparticles. Pharm. Res., 25, 55–71 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Saag, K. G., Glucocorticoid use in rheumatoid arthritis. Curr. Rheumatol. Rep., 4, 218–225 (2002).

    Article  PubMed  Google Scholar 

  • Schiffelers, R. M., Koning, G. A., Ten Hagen, T. L., Fens, M. H., Schraa, A. J., Janssen, A. P., Kok, R. J., Molema, G., and Storm, G., Anti-tumor efficacy of tumor vasculaturetargeted liposomal doxorubicin. J. Control. Release, 91, 115–122 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Schmitt, F., Lagopoulos, L., Kauper, P., Rossi, N., Busso, N., Barge, J., Wagnieres, G., Laue, C., Wandrey, C., and Juillerat-Jeanneret, L., Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. J. Control. Release, 144, 242–250 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Senolt, L., Vencovsky, J., Pavelka, K., Ospelt, C., and Gay, S., Prospective new biological therapies for rheumatoid arthritis. Autoimmun. Rev., 9, 102–107 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Sharma, G., Valenta, D. T., Altman, Y., Harvey, S., Xie, H., Mitragotri, S., and Smith, J. W., Polymer particle shape independently influences binding and internalization by macrophages. J. Control. Release, 147, 408–412 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Shehata, T., Ogawara, K., Higaki, K., and Kimura, T., Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. Int. J. Pharm., 359, 272–279 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Shi, Q., Wang, H., Tran, C., Qiu, X., Winnik, F. M., Zhang, X., Dai, K., Benderdour, M., and Fernandes, J. C., Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis. J. Biomed. Biotechnol., 2011, 148763 (2011).

    Article  PubMed  Google Scholar 

  • Shive, M. S. and Anderson, J. M., Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev., 28, 5–24 (1997).

    Article  PubMed  Google Scholar 

  • Simon, L. S., DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Int. J. Clin. Pract., 54, 243–249 (2000).

    PubMed  CAS  Google Scholar 

  • Smolen, J. S. and Steiner, G., Therapeutic strategies for rheumatoid arthritis. Nat. Rev. Drug Discov., 2, 473–488 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Solomon, D. H., Katz, J. N., Jacobs, J. P., La Tourette, A. M., and Coblyn, J., Management of glucocorticoid induced osteoporosis in patients with rheumatoid arthritis: Rates and predictors of care in an academic rheumatology practice. Arthritis Rheum., 46, 3136–3142 (2002).

    Article  PubMed  Google Scholar 

  • Strand, V., Kimberly, R., and Isaacs, J. D., Biologic therapies in rheumatology: lessons learned, future directions. Nat. Rev. Drug Discov., 6, 75–92 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Svensson, B., Boonen, A., Albertsson, K., Van Der Heijde, D., Keller, C., and Hafstrom, I., Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a twoyear randomized trial. Arthritis Rheum., 52, 3360–3370 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Tarner, I. H., Harle, P., Muller-Ladner, U., Gay, R. E., and Gay, S., The different stages of synovitis: acute vs chronic, early vs late and non-erosive vs erosive. Best Pract. Res. Clin. Rheumatol., 19, 19–35 (2005).

    Article  PubMed  Google Scholar 

  • Tarner, I. H. and Muller-Ladner, U., Drug delivery systems for the treatment of rheumatoid arthritis. Expert Opin. Drug Deliv., 5, 1027–1037 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Tomita, T., Takeuchi, E., Tomita, N., Morishita, R., Kaneko, M., Yamamoto, K., Nakase, T., Seki, H., Kato, K., Kaneda, Y., and Ochi, T., Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum., 42, 2532–2542 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Torchilin, V., Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev., 63, 131–135 (2011).

    Article  PubMed  CAS  Google Scholar 

  • Turk, M. J., Breur, G. J., Widmer, W. R., Paulos, C. M., Xu, L. C., Grote, L. A., and Low, P. S., Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum., 46, 1947–1955 (2002).

    Article  PubMed  Google Scholar 

  • Utada, A. S., Lorenceau, E., Link, D. R., Kaplan, P. D., Stone, H. A., and Weitz, D. A., Monodisperse double emulsions generated from a microcapillary device. Science, 308, 537–541 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Van Der Heijden, J. W., Oerlemans, R., Dijkmans, B. A., Qi, H., Van Der Laken, C. J., Lems, W. F., Jackman, A. L., Kraan, M. C., Tak, P. P., Ratnam, M., and Jansen, G., Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum., 60, 12–21 (2009).

    Article  PubMed  Google Scholar 

  • Van Vollenhoven, R. F., Treatment of rheumatoid arthritis: state of the art 2009. Nat. Rev. Rheumatol., 5, 531–541 (2009).

    Article  PubMed  Google Scholar 

  • Vanniasinghe, A. S., Bender, V., and Manolios, N., The potential of liposomal drug delivery for the treatment of inflammatory arthritis. Semin. Arthritis Rheum., 39, 182–196 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Wallis, W. J., Simkin, P. A., and Nelp, W. B., Protein traffic in human synovial effusions. Arthritis Rheum., 30, 57–63 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Wang, D., Miller, S. C., Liu, X. M., Anderson, B., Wang, X. S., and Goldring, S. R., Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res. Ther., 9, R2 (2007).

    Google Scholar 

  • Wolfe, F., Mitchell, D. M., Sibley, J. T., Fries, J. F., Bloch, D. A., Williams, C. A., Spitz, P. W., Haga, M., Kleinheksel, S. M., and Cathey, M. A., The mortality of rheumatoid arthritis. Arthritis Rheum., 37, 481–494 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Ye, J., Wang, Q., Zhou, X., and Zhang, N., Injectable actaritloaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int. J. Pharm., 352, 273–279 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Yoo, J. W., Chambers, E., and Mitragotri, S., Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr. Pharm. Des., 16, 2298–2307 (2010a).

    Article  PubMed  CAS  Google Scholar 

  • Yoo, J. W., Doshi, N., and Mitragotri, S., Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry. Macromol. Rapid Commun., 31, 142–148 (2010b).

    Article  PubMed  CAS  Google Scholar 

  • Yoo, J. W. and Mitragotri, S., Polymer particles that switch shape in response to a stimulus. Proc. Natl. Acad. Sci. U. S. A., 107, 11205–11210 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Yoo, J. W., Doshi, N., and Mitragotri, S., Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery. Adv. Drug Deliv. Rev., 63, 1247–1256 (2011a).

    Article  PubMed  CAS  Google Scholar 

  • Yoo, J. W., Irvine, D. J., Discher, D. E., and Mitragotri, S., Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov., 10, 521–535 (2011b).

    Article  PubMed  CAS  Google Scholar 

  • Zhigaltsev, I. V., Maurer, N., Edwards, K., Karlsson, G., and Cullis, P. R., Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention. J. Control. Release, 110, 378–386 (2006).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jin-Wook Yoo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitragotri, S., Yoo, JW. Designing micro- and nano-particles for treating rheumatoid arthritis. Arch. Pharm. Res. 34, 1887–1897 (2011). https://doi.org/10.1007/s12272-011-1109-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-011-1109-9

Key words

Navigation